1NIH consensus development panel on osteoporosis prevention,diagnosis,and therapy.Osteoporosis prevention,diagnosis,and therapy.JAMA,2001,285:785-795.
2Watts NB.Bone quality:getting closer to a definition.J Bone Miner Res,2002,17:1148-1150.
3Cummings SR,Karpf DB,Harris F,et al.Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs.Am J Med,2002,112:281-289.
4Turner CH.Biomechanics of bone:determinants of skeletal fragility and bone quality.Osteoporos Int,2002,13:97-104.
5Garnero P,Malmann D,Munoz F,et al.Long-term variability of bone markers of bone turnover in postmenopausal women and implicalions for their clinical utility.J Bone Miner Res,2002,17(Suppl 1) S299.
7Eastell R,Barton I,Hannon RA,et al.Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.J Bone Miner Res,2003,18:1051-1056.
10Delmas PD.How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis? Bone,2000,27:1-3.
二级参考文献35
11，Devogelaer J P,Broll H,Correa-Rotter R,et al.Oral alendronate induces progressive increases in bone mass of the spine,hip,and total body over 3 years in postmenopausal women with osteoporosis.Bone,1996;18(2):141
22，Balena R,Toolan BG,Shea M,et al.The effects of two-year treatment with aminophosphonate alendronate on bone metabolism,bone histomorphometry,and bone strength in ovariectomized nonhuman primates.J Clin Invest,1993;92:2577
33，Chesnut CH Ⅲ,McCkung MR,Ensrud KE,et al.Alendronate treatment of postmenopausal osteoporotic women:effect of multiple dosage on bone mass and bone remodeling.Am J Med,1995;99:144
44，Genant HK,Grampp S,Gluer CC,et al.Universal standarization for dual X-ray absorptiometry:patient and phantom cross-calibration results.J B M R,1994;9(10):1503
66，Stegman MR,Heaney RP,Travers G,et al.Cortical ultrasound velocity as an indicator of bone status.Osteoporosis Int,1995;5:349
77，Toolan BC,Shea M,Myer ER,et al.Effect of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rate.J Bone Miner Res,1992;12(11):1399
88，Black DM,Cumming SR,Karpt DB,et al.Randomised trial of alendronate on risk of fracture in women with existing vertebral fractures.The Lancet,1996;348(9401):1535
99，Pedrazzoni M,Alfano FS,Gatti C,et al.Acute effects of bisphosphonates on new and traditional markers of bone resorption.Calcif Tissue Int,1995;57:25
10World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis.WHO Technical Report Series. Geneva: WHO, 1994. 843.
